Oral GLP-1 drugs may quiet the brain’s food craving circuit

ScienceDaily is reporting on research into newer oral medications related to semaglutide—the active ingredient in Ozempic. In mice, these drugs reduced pleasure-driven eating by quieting a deep brain reward circuit, a finding that could open new avenues for understanding food cravings and potentially treating substance use disorder.

Listen to this story

Hear this and more stories in a personalized audio briefing.

Open The Chonkerton